20 research outputs found

    Non-Markovian Decay of a Three Level Cascade Atom in a Structured Reservoir

    Get PDF
    We present a formalism that enables the study of the non-Markovian dynamics of a three-level ladder system in a single structured reservoir. The three-level system is strongly coupled to a bath of reservoir modes and two quantum excitations of the reservoir are expected. We show that the dynamics only depends on reservoir structure functions, which are products of the mode density with the coupling constant squared. This result may enable pseudomode theory to treat multiple excitations of a structured reservoir. The treatment uses Laplace transforms and an elimination of variables to obtain a formal solution. This can be evaluated numerically (with the help of a numerical inverse Laplace transform) and an example is given. We also compare this result with the case where the two transitions are coupled to two separate structured reservoirs (where the example case is also analytically solvable)

    Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

    Get PDF
    BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further cancer risk-modifying loci, we performed a multi-stage GWAS of 11,705 BRCA1 carriers (of whom 5,920 were diagnosed with breast and 1,839 were diagnosed with ovarian cancer), with a further replication in an additional sample of 2,646 BRCA1 carriers. We identified a novel breast cancer risk modifier locus at 1q32 for BRCA1 carriers (rs2290854, P = 2.7×10-8, HR = 1.14, 95% CI: 1.09-1.20). In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4×10-8, HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4×10-8, HR = 1.20, 95% CI: 1.17-1.38). The 4q32.3 locus was not associated with ovarian cancer risk in the general population or BRCA2 carriers, suggesting a BRCA1-specific associat

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    The Cork City Flood of November 2009 : lessons for flood risk management and climate change adaptation at the urban scale

    Get PDF
    Flood hazards are a pressing challenge in several Irish and European cities and their impacts seem likely to intensify as climate change brings sea level rise, changes in storm patterns and increases in rainfall. Drawing on the example of Cork City and the November 2009 flood in particular, this paper evaluates contemporary policy and decision-making responses to flood hazards to determine whether they are sufficient to address current and future flood risks and vulnerabilities. It is clear that current policy and practice remains heavily influenced by a risk management paradigm that emphasises physical exposure and largely ignores socio-economic vulnerability. Floods and the losses they induce are seen as identical while engineering and technological fixes are viewed as the optimal means of reducing future flood losses. This framing of flood hazards is shaped by several influences including the historic evolution of flood policy and current institutional structures. The November 2009 flood highlights the limits of current policy and practice. Recent changes in national and European policy may also prove to be ineffective in facilitating effective adaptation and further changes in policy and practice are likely to be required
    corecore